Created at Source Raw Value Validated value
March 4, 2022, 2 p.m. oms

1) Positive SARS-CoV-2 test (confirmed by antigen test or nucleic acid detection test using samples collected within 2 weeks before eligibility evaluation)2) After 4 days from the onset ( If the onset date is unknown, the SARS-CoV-2 test date will be used. )3) High fever (38.0 degrees or higher) within 24 hours before inclusion (body temperature may be confirmed by the patient's fever record or accommodation facility record). 4) The age at the time of obtaining consent is 20 to 74 years old5) Those who understand the contents of the clinical trial and can obtain written consent to participate in the trial.

1) Positive SARS-CoV-2 test (confirmed by antigen test or nucleic acid detection test using samples collected within 2 weeks before eligibility evaluation)2) After 4 days from the onset ( If the onset date is unknown, the SARS-CoV-2 test date will be used. )3) High fever (38.0 degrees or higher) within 24 hours before inclusion (body temperature may be confirmed by the patient's fever record or accommodation facility record). 4) The age at the time of obtaining consent is 20 to 74 years old5) Those who understand the contents of the clinical trial and can obtain written consent to participate in the trial.

Feb. 11, 2022, 8 a.m. oms

1) Positive SARS-CoV-2 test (confirmed by antigen test or nucleic acid detection test using samples collected within 2 weeks before eligibility evaluation)2) After 4 days from the onset3) High fever (38.0 degrees or higher) within 24 hours before inclusion (body temperature may be confirmed by the patient's fever record or accommodation facility record). If the onset date is unknown, the SARS-CoV-2 test date will be used. )4) The age at the time of obtaining consent is 20 to 74 years old5) Those who understand the contents of the clinical trial and can obtain written consent to participate in the trial.

1) Positive SARS-CoV-2 test (confirmed by antigen test or nucleic acid detection test using samples collected within 2 weeks before eligibility evaluation)2) After 4 days from the onset3) High fever (38.0 degrees or higher) within 24 hours before inclusion (body temperature may be confirmed by the patient's fever record or accommodation facility record). If the onset date is unknown, the SARS-CoV-2 test date will be used. )4) The age at the time of obtaining consent is 20 to 74 years old5) Those who understand the contents of the clinical trial and can obtain written consent to participate in the trial.